Navigation Links
Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results
Date:2/17/2009

angible asset, net 12,387 13,548 Property and equipment, net 13,238 15,460 Marketable securities, non-current 3,145 23,882 Other assets 969 3,931 Total assets $79,780 $160,540 LIABILITIES AND STOCKHOLDERS' EQUITY Accounts payable and accrued expenses $13,136 $21,809 Deferred revenue, related party 5,965 8,372 Other current liabilities 475 553 Total current liabilities 19,576 30,734 Long-term obligations 17,061 19,107 Deferred revenue, related party, net of current portion 35,790 41,861 Total liabilities 72,427 91,702 Stockholders' equity 7,353 68,838 Total liabilities and stockholders' equity $79,780 $160,540

    Idenix Pharmaceuticals' Contacts:
    Media: Teri Dahlman (617) 995-9905
    Investors: Amy Sullivan (617) 995-9838


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
2. Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results
3. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
4. Idenix to Host Conference Call Discussing Fourth Quarter 2007 Financial Results
5. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
6. Idenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Idenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
8. Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference
9. Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results
10. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
11. Idenix to Host Conference Call Discussing Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... PA (PRWEB) January 15, 2014 The Pittcon ... publisher of Food Safety Tech , an e-Journal and ... signed an agreement for the second year for the co-location ... Pittcon 2014. The partnership provides that the registration fee to ...
(Date:1/15/2014)... 2014 Cynvenio, a cancer diagnostics company ... genomic analysis of tumor cells in the bloodstream, today ... cancer decision support application powered by CollabRx, Inc. ... genomic test, Therapy Finder will provide breast cancer patients ...
(Date:1/15/2014)... 15, 2014 This webinar will focus ... clinical safety assessment in biosimilars. , Regulatory frameworks are ... drug development, however the complex nature of biopharmaceuticals makes ... and efficacy extremely challenging. Based on the specific aspects ...
(Date:1/15/2014)... VA (PRWEB) January 15, 2014 Two ... have continued their sponsorship of an annual competition for ... in, and access to, innovative STEM study. The competition ... TEAMS: Tests of Engineering Aptitude, Mathematics, and Sciences ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), a ... of peripheral vascular disease,announced today that it plans to ... 30, 2008, after the close of market on October ... teleconference at 2:00 p.m. PT,/ 5:00 p.m. ET on ...
... Cash On Hand and No Debt, NAPA, Calif., ... life sciences company engaged in the development,of technologies that ... company continues to maintain a strong, debt-free financial,position. Current ... Million,of which is invested in fully FDIC insured bank ...
... Die of Diabetes, BRUSSELS, October 13 The ... together key opinion,leaders to push for action to secure ... countries without access to care., The meeting, Access ... will be held on Saturday, October 25 in London, ...
Cached Biology Technology:VNUS Medical Technologies to Report Third-Quarter 2008 Results and Webcast Teleconference on October 29 2Senetek Affirms Strong Financial Position 2Senetek Affirms Strong Financial Position 3International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 2International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 3
(Date:4/23/2014)... of dementia and affects some 400,000 people in Spain ... One of the reasons for this is the lack ... in nerve transmissions and the loss of memory in ... Institute of Neuroscience at the Universitat Autnoma de Barcelona ... and were able to develop a gene therapy which ...
(Date:4/23/2014)... is leading a 2 million Food Standards Agency (FSA) ... premises and industry workers. , Norovirus outbreaks can ... a batch of frozen strawberries infected 11,000 people in ... understanding of which strains cause infection and which foods ... , Researchers will produce data that will help ...
(Date:4/22/2014)... of Montana,s Wildlife Biology Program, co-wrote a research paper published ... of Sciences on how streamwater chemistry varies across a ... Lowe and co-authors from ... the Cary Institute of Ecosystem Studies, the University of Connecticut ... water samples collected every 10 meters along 32 tributaries of ...
Breaking Biology News(10 mins):Loss of memory in Alzheimer's mice models reversed through gene therapy 2New research focuses on streamwater chemistry, landscape variation 2
... , LAKE MARY, Fla. , April 26 Roundtable Concepts ... are of the highest quality components and specifications. A great review has been ... limited time only, is offering this promotional special: the RTC View 32" LCD ... at www.rtcview.com . , , ...
... 26 Kevin Harvick and the Shell-Pennzoil ... in a NASCAR Sprint Cup Series points-scoring race.  The Shell-Pennzoil ... Aaron,s 499 at Talladega Superspeedway where Harvick made a last-lap ... just 0.011 seconds to spare.  The finish was the eighth ...
... , April 26 Desarrolladora Homex,S.A.B. de C.V. ("Homex" or ... Quarter ended on March 31, 2010 (1). , ... As previously stated, effective ... Homex recognizes its revenues, costs and expenses when the,Company has transferred the ...
Cached Biology News:Roundtable Concepts Inc., the Company that has Officially Licensed Marvel Comic TVs and Officially Licensed Collegiate TVs, has just Launched their Own Line of HDTVs Named RTC View 2Harvick Breaks 115-Race Winless Streak To Take the Checkered Flag in Dramatic Finish at Talladega 2Harvick Breaks 115-Race Winless Streak To Take the Checkered Flag in Dramatic Finish at Talladega 3Harvick Breaks 115-Race Winless Streak To Take the Checkered Flag in Dramatic Finish at Talladega 4Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 2Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 3Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 4Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 5Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 6Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 7Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 8
Anti-Chicken IgY, (IgG) F(ab')2 Fragment Specific....
Presenilin 2 Immunogen: Synthetic peptide corresponding to residues 31-47 of human Presenilin 2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Recognizes TWIK-2. Does not cross react with any other known proteins....
Sheep polyclonal to ErbB 2 ( Abpromise for all tested applications). Antigen: Recombinant full length c-ErbB2 protein (Human). Entrez GeneID: 2064 Swiss Protein ID: P04626...
Biology Products: